Danish vaccine maker Bavarian Nordic A/S has submitted data to the EMA that support label extension of its mpox vaccine imvanex indication to include adolescents 12 to 17 years of age.
https://european-biotechnology.com/wp-content/uploads/2024/08/Bavarian-Nordic-production-site-in-kvistgaard.jpg317634Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-08-16 10:37:002024-10-08 09:40:07Bavarian Nordic A/S applies for EU label extension of mpox vaccine
After the drug discovery specialist Evotec SE lowered its annual forecast and lost almost 75% of its market capitalisation in just eight months, the new CEO, Christian Wojczewski, is taking action and closing non-profitable areas.
Investigating substrate selectivity of nitrogenase enzymes in phototrophic R. capsulatus bacteria, German microbiologist have found one converting CO2 to formiate and methane opening the way to fossil oil-free hydrocarbon synthesis
https://european-biotechnology.com/wp-content/uploads/2024/08/Nitrogenase-e1723631271837.jpeg393700Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-08-15 08:14:552025-02-01 12:23:52Nitrogenases also can fix CO2
https://european-biotechnology.com/wp-content/uploads/2024/08/penKid-measurement_tg-e1723451171706.png8441499Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-08-12 10:30:302024-08-12 10:30:30Sphingotec secures Series C financing
A Dutch-German resarch team together with Evotec SE have presented a new class of vancomycin derivatives with good safety profile that kill multi-resistant, Gram-positive bugs.
https://european-biotechnology.com/wp-content/uploads/2024/08/EB.com_kl._Helene-Sicard.c-Jean-Marie-Huron-for-DiogenX.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2024-08-07 10:47:392024-08-23 10:53:32DiogenX strengthens its management team
After Sangamo Therapeutics Inc. presented an epigenetic ZFN-based repressor at ASGCT 2024 that reduces the expression of the tau protein in the hippocampus by 95% in Alzheimer’s models, Roche’s US subsidiary Genentech has licensed the experimental gene therapy.
French bioplastics recycling specialist Carbios SAS and British recycling and waste management company FCC Environment want to establish a PET biorecycling facility in the UK.
https://european-biotechnology.com/wp-content/uploads/2024/08/carbios-ur-architectural-view.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2024-08-06 12:02:072024-08-06 12:02:22Carbios SAS to expand PET recycling portfolio to the UK
The US Food & Drug Administration has granted accelerated approval to Adaptimmune’s Tecelra as the world’s first therapy with genetically engineered T cells to fight a solid tumour.
Lori A. Ball has been appointed as the new Chief Executive Officer of UK-based Astoriom. She will be responsible for driving the development of Astoriom’s sample management business in the US, UK and Europe.
https://european-biotechnology.com/wp-content/uploads/2024/08/EB.com_Lori-A.-Ball_.jpg472420Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2024-08-02 14:46:042024-08-22 14:51:25Experienced CEO appointed
Bavarian Nordic A/S applies for EU label extension of mpox vaccine
Latest NewsDanish vaccine maker Bavarian Nordic A/S has submitted data to the EMA that support label extension of its mpox vaccine imvanex indication to include adolescents 12 to 17 years of age.
Evotec axes 400 jobs worldwide
Latest NewsAfter the drug discovery specialist Evotec SE lowered its annual forecast and lost almost 75% of its market capitalisation in just eight months, the new CEO, Christian Wojczewski, is taking action and closing non-profitable areas.
Nitrogenases also can fix CO2
Latest NewsInvestigating substrate selectivity of nitrogenase enzymes in phototrophic R. capsulatus bacteria, German microbiologist have found one converting CO2 to formiate and methane opening the way to fossil oil-free hydrocarbon synthesis
Sphingotec secures Series C financing
Latest NewsGerman diagnostics specialist SphingoTec GmbH has closed a €5m Series C financing round led by Think.Health Ventures.
New antibiotic breaks resistance
Latest NewsA Dutch-German resarch team together with Evotec SE have presented a new class of vancomycin derivatives with good safety profile that kill multi-resistant, Gram-positive bugs.
DiogenX strengthens its management team
AppointmentsThe biotech company DiogenX, based in Marseille (F), has appointed Hélène Sicard, PhD, as Chief Development Officer.
Roche inks US$2bn biobucks deal with Sangamo
Latest NewsAfter Sangamo Therapeutics Inc. presented an epigenetic ZFN-based repressor at ASGCT 2024 that reduces the expression of the tau protein in the hippocampus by 95% in Alzheimer’s models, Roche’s US subsidiary Genentech has licensed the experimental gene therapy.
Carbios SAS to expand PET recycling portfolio to the UK
Latest NewsFrench bioplastics recycling specialist Carbios SAS and British recycling and waste management company FCC Environment want to establish a PET biorecycling facility in the UK.
FDA approves cell therapy for solid tumours
Latest NewsThe US Food & Drug Administration has granted accelerated approval to Adaptimmune’s Tecelra as the world’s first therapy with genetically engineered T cells to fight a solid tumour.
Experienced CEO appointed
AppointmentsLori A. Ball has been appointed as the new Chief Executive Officer of UK-based Astoriom. She will be responsible for driving the development of Astoriom’s sample management business in the US, UK and Europe.